Navigation Links
Clinical trial evaluating brain cancer vaccine is underway at NYU
Date:10/19/2007

NEW YORK, October 18, 2007 A clinical trial evaluating a brain cancer vaccine in patients with newly diagnosed brain cancer has begun at NYU Medical Center. The study will evaluate the addition of the vaccine following standard therapy with surgery and chemotherapy in patients with glioblastoma multiforme, a deadly form of brain cancer.

The vaccine, called DCVax-Brain, incorporates proteins found in patients tumors and is designed to attack cancer cells containing these proteins. The study underway at NYU Medical Center is an expansion of an earlier phase I trial of the vaccine. The vaccine is made by the Northwest Biotherapeutics, Inc., based in Bothell, Washington.

We are really excited about the promise of this vaccine, said Patrick J. Kelly, M.D., the chairman of the Department of Neurosurgery and the Joseph Ransohoff Professor of Neurosurgery at NYU School of Medicine. Everything now depends on something in addition to surgery so that these tumors do not recur. A cancer vaccine like this may make a difference in extending life and maintaining a good quality of life.

This is a form of individualized therapy, adds NYU neuro-oncologist Michael Gruber, M.D. There is a lot of promise with this approach, he says. He and Dr. Kelly will be the lead investigators conducting the trial at NYU.

Despite surgery and chemotherapy, patients with glioblastoma multiforme brain cancer typically survive about 15 months. Even if only a small number of tumor cells are left in the brain, that is enough for these fast growing and aggressive tumors to grow back. The tumors do not grow elsewhere in the body. It is so frustrating, notes Dr. Kelly, because brain tumors dont metastasize like other tumors. They recur locally but we just cant cure it.

A brain cancer vaccine is intended as a kind of immunotherapy, which means that it primes the patients own immune system to kill proteins found in cancer cells. Th
'/>"/>

Contact: Pamela McDonnell
Pamela.Mcdonnell@nyumc.org
212-404-3555
New York University Medical Center and School of Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. How do patients benefit of clinical trials
2. Magnetic resonance angiography in clinical medicine
3. Clinical trials need to be more frank
4. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
5. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
6. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
7. Clinical Comparisons Between ADHD Drugs Are Less
8. Outsourcing clinical trials to India
9. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
10. India to maintain Public domain Registry database of clinical trials conducted in India.
11. A Novel System For Clinical Banking Of Umbilical Cord Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... William Mattar ... William Mattar, Esq. believes this does not stop at any certain demographic or segment ... its newly produced one-minute, thirty-, fifteen- and ten-second TV commercials. , The closed captioning ...
(Date:9/3/2015)... ... 03, 2015 , ... Topical BioMedics, Inc., hosted Amsterdam resident ... six-month, 10,000 mile journey from Santiago, Chile to Times Square and then Rhinebeck, ... Las Americas” project—Max crossed six countries in 168 days on his 39-year-old Moto ...
(Date:9/3/2015)... ... September 03, 2015 , ... Silverado next week lays ... Columbine Drive in Bellingham, Washington. Silverado Bellingham, a 41,000 square foot, single-story community, ... serve up to 80 people living with Alzheimer’s, dementia and other memory-impairing conditions. ...
(Date:9/3/2015)... ... September 03, 2015 , ... RealtyShares , the online ... institutional investors to real estate investment opportunities nationwide, today announced that it is ... investors and sponsoring real estate companies. , These products typically involve ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... Intellicure, Inc., in its Annual Inc. 5000 list of fastest-growing private companies ... "only a tiny fraction of the nation's companies have demonstrated such remarkably consistent ...
Breaking Medicine News(10 mins):Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:Site Dedication Ceremony to Celebrate New Silverado Memory Care Community 2Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2
... and Caitlin Mason from Queens University, Canada has reported in ... national surveys which reported the obesity// and overweight in Canadian ... between 1985 to 2003. The study showed an increasing trend ... a shift in BMI index from Class II to Class ...
... like that of viral flu are spreading across Delhi with ... a minimum of 0.2 degrees Celsius (7 degrees below normal) ... reached 11.6 degrees //(five degree above normal) on 17 January ... the weather change. ,‘There is a sudden ...
... approved the drug for use to treat the cancer multiple ... the Department of Health and Ageing. It is available through ... is to go to the PBS," as said by the ... the drug was originally used in Australia in the late ...
... died in Singapore a few days after the operation, and ... is reported to have suffered from a heart attack while ... transplant surgeon K.C. Tan. ,The recipient, a ... enough to go home. Tan said the donor was put ...
... of Science throws light on cells that could prevent ... in the February issue of Nature Neuroscience. ... led the study, //which might have important implication in ... The researchers say that immune cells play a key ...
... 39-year-old Mogjan Azari, a dentist who was jailed for one ... and is banned from practicisig. Azari allowed her boyfriend Omid ... devastating consequences. ,Mazaheri practiced on Azari's patients without ... days. On one occasion he broke a syringe in a ...
Cached Medicine News:Health News:Weizmann Institute of Science says Immune Cells Could Help Maintain Brain Function 2
(Date:9/3/2015)... , Sept. 3, 2015 Research and Markets ... "Radiology Information Systems Market by Type, Deployment Mode, ... Forecast to 2019" report to their offering. ... estimated at $501.1 Million 2014, and is projected to ... 7.6% from 2014 to 2019. The ...
(Date:9/3/2015)... -- The findings of a year-long investigation conducted by NBC ... handling of its Recovery IVC filter product ... part one of the series revealed that ... fatalities, have been associated with the Recovery device. NBC ... Bard in 2004 which linked the Recovery IVC filter ...
(Date:9/3/2015)... DUBLIN , Sep. 03, 2015 ... announced the addition of the "Investigation Report on ... As air pollution worsens, the incidence of ... size of relevant drugs. Bromhexine, a semisynthetic derivative of ... of chronic bronchitis and asthma associated with viscid or ...
Breaking Medicine Technology:Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 2Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 3IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 2IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 3China Bromhexine Market Report 2015-2019 2
... Anpath Group, Inc.,(OTC Bulletin Board: ANPG), ... (ESI) announced the selection of its,disinfectant, EnviroTru(TM) ... Authority (Metro). EnviroTru(TM) is a multi-purpose ... and also meets EPA requirements for,Toxicity Category ...
... Presented at Anti-Angiogenesis Conference Shows R84, the Selective Human ... Affitech, Is Equivalent to Avastin in Inhibiting Growth of Established ... Tumors in a Preclinical Breast Cancer Model -- ... a Potential Clinical Candidate --, BOSTON and TUSTIN, Calif., ...
Cached Medicine Technology:Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro) 2Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro) 3New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models 2New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models 3New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models 4New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models 5
Farabeuf periosteal elevators....
OHL periosteal elevator, 19 cm, 7-1/2"....
Steinhauser periosteal elevator....
Dolwick-Reich Condyle periosteal elevator, 17.5 cm, 7"....
Medicine Products: